A study to assess the effectiveness and safety of EPANOVA™ in patients who have severe hypertriglyceridemia, when compared to treatment with olive oil over 12 weeks
- Registry ID
- EUCTR2013-004682-14
- Source registry
- EUCTR
- Status
- Completed
- Phase
- PHASE3
- Sponsor
- Omthera Pharmaceuticals, Inc.
- Start date
- 2014-04-15
- Completion date
- 2014-12-23
- Last update
- 2026-08-16
Conditions
- Severe hypertriglyceridemia
Summary
The primary objectives of the study are:
• To determine the efficacy of Epanova 2 g daily compared to olive oil 2 g daily for 12 weeks in lowering serum triglyceride (TG) levels in subjects with severe hypertriglyceridemia (TG levels ≥500 mg/dL [5.65 mMol/L] and <2500 mg/dL [28.25 mMol/L])
• To determine the safety and tolerability of Epanova.
Locations
- , , Netherlands
- , , Hungary
- , , Denmark
- , , Czechia
View on source registry